ReviewJTO clinical and research reports2021

Important Surgical and Clinical End Points in Neoadjuvant Immunotherapy Trials in Resectable NSCLC.

Jay M Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.